Physician profile
Joel Ornelas
NPI 1528290509
$8,075.47
in general payments reported to CMS, 2019-2025
12 companies · $2,284 in 2025
The $2,284 reported for 2025 was more than what 91% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $800 · 2021: $131 · 2022: $1,958 · 2023: $381 · 2024: $1,585 · 2025: $2,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,347 · Food and Beverage: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,346.54 |
| Food and Beverage | $1,903.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,541.50 | 2020-2025 | Indigo System |
| Boston Scientific Corporation | $643.02 | 2019-2024 | Eluvia, Truselect |
| Terumo Medical Corporation | $403.60 | 2019-2020 | |
| Argon Medical Devices, INC. | $400.00 | 2020 | |
| Medtronic USA, INC. | $268.04 | 2019 | |
| Inari Medical, INC. | $258.48 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $193.80 | 2023-2024 | In.Pact Av, Abre |
| Medtronic Vascular, INC. | $118.90 | 2019 | |
| Endocare, INC. | $109.15 | 2019 | |
| Cook Medical LLC | $58.48 | 2022 | |
| W. L. Gore & Associates, INC. | $57.17 | 2019 | |
| Blue Earth Diagnostics | $23.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Ornelas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.